• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Evonik

    Zealand Pharma Announces Positive Results from Phase 3 Trial of Glepaglutide

    01 Oct 2022 //

    BENZINGA

    Advancement of Clinical Pipeline; Key Data for Glepaglutide and Dasiglucagon

    11 Mar 2022 //

    GLOBENEWSWIRE

    Zealand Pharma Completes Enrollment in EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide in Patients with Short Bowel Syndrome

    20 Jan 2022 //

    PRESS RELEASE

    Zealand Pharma Announces patient dosing in Phase 3b trial in Glepaglutide

    19 Aug 2021 //

    GLOBENEWSWIRE

    Zealand Pharma to Present Data on Glepaglutide at the 17th CIRTA

    29 Jun 2021 //

    GLOBENEWSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.